Cargando…

The case for home monitoring in hypertension

Although the assessment of cardiovascular risk in individual patients takes into account a range of risk factors, the diagnosis and management of hypertension (high blood pressure) is largely determined by a single numerical value, albeit that often several readings are taken over time. Given the cr...

Descripción completa

Detalles Bibliográficos
Autor principal: Padfield, Paul L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958151/
https://www.ncbi.nlm.nih.gov/pubmed/20875117
http://dx.doi.org/10.1186/1741-7015-8-55
_version_ 1782188305516855296
author Padfield, Paul L
author_facet Padfield, Paul L
author_sort Padfield, Paul L
collection PubMed
description Although the assessment of cardiovascular risk in individual patients takes into account a range of risk factors, the diagnosis and management of hypertension (high blood pressure) is largely determined by a single numerical value, albeit that often several readings are taken over time. Given the critical impact of a decision to embark on lifelong drug therapy, the importance of ensuring that a blood pressure (BP) record is both accurate and representative is clear. However, there is good evidence that the variability of BP is such that even if measurement is of the highest quality, it can be difficult to say with confidence whether a patient is above or below a treatment threshold. This commentary argues that current BP measurement is inadequate to make the clinical decisions that are necessary and that multiple readings are required to deliver an acceptable degree of accuracy for safe decision-making. This is impractical in a doctor's surgery, and the only realistic long-term strategy is to involve the patient in measuring his or her own BP in their own environment. Evidence is presented that such a strategy is better able to predict risk, is cost-effective for diagnosing hypertension, can improve BP control and is thus better able to protect individuals in the future. In this commentary, I explain why doctors and other healthcare professionals should increase their familiarity with the technology, be aware of its strengths and limitations and work with patients as they become more empowered in the management of their chronic condition, hypertension.
format Text
id pubmed-2958151
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29581512010-10-21 The case for home monitoring in hypertension Padfield, Paul L BMC Med Commentary Although the assessment of cardiovascular risk in individual patients takes into account a range of risk factors, the diagnosis and management of hypertension (high blood pressure) is largely determined by a single numerical value, albeit that often several readings are taken over time. Given the critical impact of a decision to embark on lifelong drug therapy, the importance of ensuring that a blood pressure (BP) record is both accurate and representative is clear. However, there is good evidence that the variability of BP is such that even if measurement is of the highest quality, it can be difficult to say with confidence whether a patient is above or below a treatment threshold. This commentary argues that current BP measurement is inadequate to make the clinical decisions that are necessary and that multiple readings are required to deliver an acceptable degree of accuracy for safe decision-making. This is impractical in a doctor's surgery, and the only realistic long-term strategy is to involve the patient in measuring his or her own BP in their own environment. Evidence is presented that such a strategy is better able to predict risk, is cost-effective for diagnosing hypertension, can improve BP control and is thus better able to protect individuals in the future. In this commentary, I explain why doctors and other healthcare professionals should increase their familiarity with the technology, be aware of its strengths and limitations and work with patients as they become more empowered in the management of their chronic condition, hypertension. BioMed Central 2010-09-27 /pmc/articles/PMC2958151/ /pubmed/20875117 http://dx.doi.org/10.1186/1741-7015-8-55 Text en Copyright ©2010 Padfield; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Padfield, Paul L
The case for home monitoring in hypertension
title The case for home monitoring in hypertension
title_full The case for home monitoring in hypertension
title_fullStr The case for home monitoring in hypertension
title_full_unstemmed The case for home monitoring in hypertension
title_short The case for home monitoring in hypertension
title_sort case for home monitoring in hypertension
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958151/
https://www.ncbi.nlm.nih.gov/pubmed/20875117
http://dx.doi.org/10.1186/1741-7015-8-55
work_keys_str_mv AT padfieldpaull thecaseforhomemonitoringinhypertension
AT padfieldpaull caseforhomemonitoringinhypertension